News

The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.

Merck logo

FDA approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for type 2 diabetes

2 February 2012
JANUMET XR can help many patients reach blood sugar goals...

AstraZeneca

AstraZeneca to cut a further 7,300 jobs

2 February 2012
AstraZeneca has announced new restructuring initiatives designed to improve productivity...

Novartis logo

FDA approves Novartis drug Glivec® label

1 February 2012
The US Food and Drug Administration has approved an update to the Glivec® (imatinib)* label...

Pfizer logo

Private and public partners unite to combat 10 neglected tropical diseases by 2020

30 January 2012
Partners pledge innovative, coordinated action aimed at new WHO goals...

Novartis logo

Novartis extends commitment to help achieve final elimination of leprosy

30 January 2012
Novartis is a part of an international effort to eliminate or control 10 NTDs by the end of the decade...

Eli Lilly logo

FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes

30 January 2012
Jentadueto™ tablets approved...

Biogen Idec logo

Biogen Idec appoints Kenneth DiPietro Executive Vice President Human Resources

30 January 2012
Kenneth DiPietro named Executive Vice President, Human Resources...

SANOFI logo

Sanofi commits to eliminate or control five neglected tropical diseases

30 January 2012
These commitments are a key part of the "Uniting to Combat Neglected Tropical Diseases" partnership...

Roche logo

FDA approves Erivedge (vismodegib) capsule

30 January 2012
The first medicine for adults with advanced basal cell carcinoma...

GlaxoSmithKline logo

GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020

30 January 2012
“United effort to free future generations from the burden of neglected tropical diseases..."

Abbott logo

DNDi and Abbott expand partnership to boost innovation for neglected tropical diseases

30 January 2012
DNDi & Abbott have signed a four-year joint research & non-exclusive licensing agreement...

Roche logo

Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash

27 January 2012
Roche has commenced a cash tender offer to acquire all outstanding shares of Illumina, Inc....